212 related articles for article (PubMed ID: 3031816)
1. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression.
Weissman BE; Saxon PJ; Pasquale SR; Jones GR; Geiser AG; Stanbridge EJ
Science; 1987 Apr; 236(4798):175-80. PubMed ID: 3031816
[TBL] [Abstract][Full Text] [Related]
2. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma.
Dowdy SF; Weissman BE; Stanbridge EJ
J Cell Physiol; 1991 May; 147(2):248-55. PubMed ID: 1645741
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenicity of a Wilms' tumor cell line is associated with a decrease in synthesis of two proteins.
Wheeler TT; Xiao JP; Dowdy SF; Stanbridge EJ; Young DA
Oncogene; 1991 Oct; 6(10):1903-7. PubMed ID: 1656366
[TBL] [Abstract][Full Text] [Related]
4. Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.
Fraizer GE; Bowen-Pope DF; Vogel AM
J Cell Physiol; 1987 Oct; 133(1):169-74. PubMed ID: 2444606
[TBL] [Abstract][Full Text] [Related]
5. A nude mouse Wilms' tumor line (KCMC-WT-1) derived from an aniridia patient with monoalleleic partial deletion of chromosome 11p.
Nagashima Y; Nishihira H; Miyagi Y; Tanaka Y; Sasaki Y; Nishi T; Imaizumi K; Aoki I; Misugi K
Cancer; 1996 Feb; 77(4):799-804. PubMed ID: 8616775
[TBL] [Abstract][Full Text] [Related]
6. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
[TBL] [Abstract][Full Text] [Related]
7. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
8. The T-ALL specific t(11;14)(p13;q11) translocation breakpoint cluster region is located near to the Wilms' tumour predisposition locus.
Boehm T; Lavenir I; Forster A; Wadey RB; Cowell JK; Harbott J; Lampert F; Waters J; Sherrington P; Couillin P
Oncogene; 1988 Dec; 3(6):691-5. PubMed ID: 2577871
[TBL] [Abstract][Full Text] [Related]
9. Human chromosome 11 suppresses the tumorigenicity of adenovirus transformed baby rat kidney cells: involvement of the Wilms' tumor 1 gene.
Menke AL; van Ham RC; Sonneveld E; Shvarts A; Stanbridge EJ; Miyagawa K; van der Eb AJ; Jochemsen AG
Int J Cancer; 1995 Sep; 63(1):76-85. PubMed ID: 7558457
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11.
Dowdy SF; Fasching CL; Araujo D; Lai KM; Livanos E; Weissman BE; Stanbridge EJ
Science; 1991 Oct; 254(5029):293-5. PubMed ID: 1656527
[TBL] [Abstract][Full Text] [Related]
11. The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney.
Garvin AJ; Re GG; Tarnowski BI; Hazen-Martin DJ; Sens DA
Am J Pathol; 1993 Feb; 142(2):375-80. PubMed ID: 8382007
[TBL] [Abstract][Full Text] [Related]
12. The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells.
Dowdy SF; Lai KM; Weissman BE; Matsui Y; Hogan BL; Stanbridge EJ
Nucleic Acids Res; 1991 Oct; 19(20):5763-9. PubMed ID: 1658743
[TBL] [Abstract][Full Text] [Related]
13. A genetic basis for tumour suppression.
Stanbridge EJ
Ciba Found Symp; 1989; 142():149-59; discussion 159-65. PubMed ID: 2545419
[TBL] [Abstract][Full Text] [Related]
14. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
15. Two anonymous DNA segments distinguish the Wilms' tumor and aniridia loci.
Davis LM; Stallard R; Thomas GH; Couillin P; Junien C; Nowak NJ; Shows TB
Science; 1988 Aug; 241(4867):840-2. PubMed ID: 2841760
[TBL] [Abstract][Full Text] [Related]
16. Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines.
Oshimura M; Kugoh H; Koi M; Shimizu M; Yamada H; Satoh H; Barrett JC
J Cell Biochem; 1990 Mar; 42(3):135-42. PubMed ID: 2318911
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular biology of Wilms' tumour.
Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
[TBL] [Abstract][Full Text] [Related]
18. Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer.
Yamada H; Wake N; Fujimoto S; Barrett JC; Oshimura M
Oncogene; 1990 Aug; 5(8):1141-7. PubMed ID: 2392323
[TBL] [Abstract][Full Text] [Related]
19. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
Kugoh HM; Hashiba H; Shimizu M; Oshimura M
Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
[TBL] [Abstract][Full Text] [Related]
20. [Genetic alterations associated with pathologic differentiation of Wilms' tumors].
Chevalier G; Perbal B
Bull Cancer; 1997 Mar; 84(3):289-303. PubMed ID: 9207876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
